Antiviral potential of lactic acid bacteria and their bacteriocins.
about
Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approachesThe Influence of the Gut Microbiota on Host Physiology: In Pursuit of MechanismsThe vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.Molecular identification and phylogenetic analysis of Lactobacillus and Bifidobacterium spp. isolated from gut of honeybees (Apis mellifera) from West Azerbaijan, Iran.Virus-Bacteria Interactions: An Emerging Topic in Human Infection.Antiviral activity and specific modes of action of bacterial prodigiosin against Bombyx mori nucleopolyhedrovirus in vitro.Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2.Bacteriocins: Not Only Antibacterial Agents.Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells.A novel kefir product (PFT) activates dendritic cells to induce CD4+T and CD8+T cell responses in vitro.In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of Hepatitis E virus capsid protein.Virus-Bacteria Interactions: Implications and Potential for the Applied and Agricultural Sciences.Functional analysis of the biosynthetic gene cluster required for immunity and secretion of a novel Lactococcus-specific bacteriocin, lactococcin Z.Enterocin B3A-B3B produced by LAB collected from infant faeces: potential utilization in the food industry for Listeria monocytogenes biofilm management.Specific properties of probiotic strains: relevance and benefits for the host
P2860
Q27012682-8ABA2117-8AF2-47C8-998A-10F4FE3D378EQ28070162-15C4329A-69D6-442C-8859-831388D8002BQ28074014-F0ED0886-6F72-4907-A36A-3948D6A6211FQ37037951-12F9EAB5-D094-4EDB-B20D-167D927761E2Q37597330-AE56AD0E-8862-47BE-AFAD-7E8FD9C37AC8Q37727858-86761CC6-0DFB-4A43-921F-95D71571859FQ38810468-6C22191A-34D1-4EF9-AA50-97A3F88FE256Q38902114-722C75E7-9BBE-494B-BDC0-7CF07D7B4717Q39294924-0D37292A-C9C6-4878-9455-976521EB6272Q40232116-7CD21BC5-F826-4CE0-BACC-CD77175518FBQ40525273-E5F9B5F2-5A72-4850-802F-D1893253AA10Q47240941-CD06F574-202F-4AC8-AA03-C40D6E24CAEDQ47546892-C2B05EE8-43C4-4727-B536-70207A742F70Q47942387-8AFF5956-2645-4055-A370-5F38926F68D9Q49959233-D6D1BBDA-CF72-4442-A62B-A9115B08A8E7Q57120630-61367D50-057B-47E8-9654-0EA92AF1242A
P2860
Antiviral potential of lactic acid bacteria and their bacteriocins.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antiviral potential of lactic acid bacteria and their bacteriocins.
@en
type
label
Antiviral potential of lactic acid bacteria and their bacteriocins.
@en
prefLabel
Antiviral potential of lactic acid bacteria and their bacteriocins.
@en
P2093
P2860
P1476
Antiviral potential of lactic acid bacteria and their bacteriocins
@en
P2093
P2860
P2888
P304
P356
10.1007/S12602-014-9162-6
P50
P577
2014-12-01T00:00:00Z
P5875
P6179
1034242542